Alps Alpine Co., Ltd. (APELY)

SpringWorks Therapeutics Revenue

Alps Alpine had revenue of 238.92B JPY in the quarter ending June 30, 2025, with 2.28% growth. This brings the company's revenue in the last twelve months to 995.73B, up 1.69% year-over-year. In the fiscal year ending March 31, 2025, Alps Alpine had annual revenue of 990.41B with 2.73% growth.

• Revenue (ttm): 995.73B JPY
• Revenue Growth: +1.69%
• P/S Ratio: 0.34
• Revenue / Employee: 36.49M JPY
• Employees: 27,287
• Market Cap: 2.24B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	990.41B	26.32B	2.73%
Mar 31, 2024	964.09B	30.98B	3.32%
Mar 31, 2023	933.11B	130.26B	16.22%
Mar 31, 2022	802.85B	84.84B	11.82%
Mar 31, 2021	718.01B	-92.56B	-11.42%